Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Hemangiosarcoma

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Hemangiosarcoma in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choorapoikayil, S1
Weijts, B1
Kers, R1
de Bruin, A1
den Hertog, J1
LaMontagne, KR1
Moses, MA1
Wiederschain, D1
Mahajan, S1
Holden, J1
Ghazizadeh, H1
Frank, DA1
Arbiser, JL1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Hemangiosarcoma

ArticleYear
Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish.
    Disease models & mechanisms, 2013, Volume: 6, Issue:5

    Topics: Animals; Chromones; Drug Therapy, Combination; Endothelial Cells; Haploinsufficiency; Hemangiosarcom

2013
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells.
    The American journal of pathology, 2000, Volume: 157, Issue:6

    Topics: Agar; Animals; Cell Cycle; Cell Division; Chromones; Dose-Response Relationship, Drug; Enzyme Inhibi

2000